Australian University Rankings Guide

Complementary Therapies in Clinical Practice (ERA Journal)

Complementary Therapies in Clinical Practice is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Complementary Therapies in Clinical Practice issns are issn1: 1744-3881 issn2: 1873-6947.

The fields covered by Complementary Therapies in Clinical Practice as part of the evaluation of Australian university research excellence are:

Complementary and Alternative Medicine Research Rankings (Sub-Field)

Nursing Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Complementary and Alternative Medicine field include:

- Alternative Medicine Review: a journal of clinical therapeutics
- Australian Journal of Acupuncture and Chinese Medicine
- Chinese Journal of Integrated Medicine
- Chinesische Medizin: theoretische Grundlagen Diagnostik Akupunktur Arzneimittel Taiji Qigong
- Evidence-Based Complementary and Alternative Medicine
- Human Genetics
- Journal of Acupuncture and Meridian Studies
- Journal of Chinese Integrative Medicine
- Journal of Complementary and Integrative Medicine
- Journal of Traditional and Complementary Medicine
- Journal of the Australian Traditional-Medicine Society
- NAMAH: a journal of Sri Aurobindo International Institute for Integral Health and Research
- Revue Francaise d'Acupuncture
- TSW Holistic Health and Medicine
- Zhongyi Zhenggu


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4